Vandely Perez
General Practice · Hialeah, FLNPI 1003848268
Payments from drug & device makers
Across 139 payments — averaging $6415.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$892K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 139 | $891,781 |
How this compares
$891,781 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 91 | $90,143 |
| EliquisApixaban | 67 | $82,584 |
| JanuviaSitagliptin Phosphate | 44 | $54,791 |
| EntrestoSacubitril/Valsartan | 48 | $47,601 |
| XareltoRivaroxaban | 29 | $43,530 |
| FarxigaDapagliflozin Propanediol | 42 | $30,818 |
| VeltassaPatiromer Calcium Sorbitex | 24 | $24,229 |
| JardianceEmpagliflozin | 13 | $18,193 |
| LinzessLinaclotide | 21 | $17,904 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 27 | $16,856 |
| TradjentaLinagliptin | 17 | $12,972 |
| BrilintaTicagrelor | 14 | $10,339 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $10,260 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $9,693 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 31 | $7,211 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $891,781 | $19,95438 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,901 general practice providers in Florida.
Other general practice in Hialeah
- Frank AlvarezHialeah$13.6M
- Manuel SanchezHialeah$5.2M
- Gustavo TorresHialeah$3M
- Maria NualartHialeah$2.7M
- Agustin RivasHialeah$2M
- Heliodoro RuizHialeah$1.6M
- Idania FernandezHialeah$1.5M
- Gilda de la CalleHialeah$1.4M
- Jose CardonaMiami$71M
- Lawrence GalitzMiami Gardens$42.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.